CVS Health Corporation (CVS) Insider Trading
Over the last 3 months, CVS insiders made 0 open-market buys and 9 sales, a net sale of -$345.7M (SEC Form 4). Over the last 6 months, 1514 institutions increased and 1535 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
9
Net (3m)
-$345.7M
Insider trades by month Buys Sells
May
Jun
Aug
Oct
Jan
May
Context3-month price +20.5%Institutions mixed (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 1, 2026 | Compton-Phillips Amyofficer: EVP, Chief Medical Officer | Tax | 7,618 | $90.98 |
| Jun 1, 2026 | Newman Brianofficer: EVP, Chief Financial Officer | Tax | 2,478 | $90.98 |
| May 21, 2026 | ROBBINS LARRYdirector | Sell | 370,462 | $93.45 |
| May 21, 2026 | ROBBINS LARRYdirector | Sell | 66,881 | $95.67 |
| May 21, 2026 | ROBBINS LARRYdirector | Sell | 151 | $95.18 |
| May 21, 2026 | ROBBINS LARRYdirector | Sell | 152,691 | $94.81 |
| May 21, 2026 | ROBBINS LARRYdirector | Sell | 1,983,387 | $94.45 |
| May 21, 2026 | ROBBINS LARRYdirector | Sell | 800 | $96.28 |
| May 21, 2026 | ROBBINS LARRYdirector | Sell | 378,000 | $58.29 |
| May 21, 2026 | ROBBINS LARRYdirector | Sell | 797,628 | $93.48 |
| May 15, 2026 | DECOUDREAUX ALECIA Adirector | Grant | 1,448 | — |
| May 15, 2026 | Balser Jeffrey R.director | Grant | 2,058 | $97.15 |
| May 15, 2026 | KIRBY J SCOTTdirector | Grant | 1,447 | $97.15 |
| May 15, 2026 | BROWN C DAVID IIdirector | Grant | 1,544 | $97.15 |
| May 15, 2026 | ROBBINS LARRYdirector | Grant | 1,930 | — |
| May 15, 2026 | Mahoney Michael Fdirector | Grant | 1,737 | — |
| May 15, 2026 | Shulman Douglas H.director | Grant | 1,448 | — |
| May 15, 2026 | Finucane Anne A.director | Grant | 1,544 | — |
| May 15, 2026 | SANSONE GUY Pdirector | Grant | 1,447 | $97.15 |
| May 15, 2026 | Norwalk Leslie Vdirector | Grant | 1,447 | $97.15 |
| May 15, 2026 | Gallina John Edirector | Grant | 1,448 | — |
| May 15, 2026 | AGUIRRE FERNANDOdirector | Grant | 1,563 | $97.15 |
| May 11, 2026 | Mandadi Tilakofficer: EVP, Chief Exp & Tech Officer | Sell | 69,551 | $89.58 |
| Apr 2, 2026 | Clark James Davidofficer: SVP, Cont & Chief Acct Officer | Grant | 11,976 | $71.82 |
| Apr 2, 2026 | Joyner J. Daviddirector, officer: President, CEO and Chair | Grant | 86,326 | $71.82 |
| Apr 2, 2026 | Clark James Davidofficer: SVP, Cont & Chief Acct Officer | Tax | 3,262 | $72.49 |
| Apr 2, 2026 | Shah Prem Sofficer: EVP and Group President | Grant | 25,062 | $71.82 |
| Apr 2, 2026 | Compton-Phillips Amyofficer: EVP, Chief Medical Officer | Grant | 35,928 | $71.82 |
| Apr 2, 2026 | Khichi Samrat S.officer: EVP, CPO and General Counsel | Grant | 80,838 | $71.82 |
| Apr 2, 2026 | Shah Prem Sofficer: EVP and Group President | Tax | 1,484 | $72.49 |
Source: CVS SEC Form 4 filings, latest Jun 1, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their CVS positions over the last 6 months (SEC Form 13F).
Increased
1514
New positions
388
Reduced
1535
Sold out
312
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | Increased | 125.9M | May 13, 2026 |
| BLACKROCK, INC. | Increased | 121.0M | Feb 12, 2026 |
| VANGUARD GROUP INC | Increased | 120.7M | Jan 29, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 82.7M | May 15, 2026 |
| CAPITAL WORLD INVESTORS | Increased | 77.2M | May 13, 2026 |
| CAPITAL WORLD INVESTORS | Reduced | 67.7M | Feb 11, 2026 |
| DODGE & COX | Reduced | 62.5M | Feb 13, 2026 |
| STATE STREET CORP | Increased | 60.2M | Feb 13, 2026 |
| STATE STREET CORP | Reduced | 59.3M | May 15, 2026 |
| DODGE & COX | Reduced | 51.8M | May 14, 2026 |
| FMR LLC | Reduced | 41.0M | Feb 17, 2026 |
| JPMORGAN CHASE & CO | Reduced | 31.2M | Feb 11, 2026 |
| FMR LLC | Reduced | 31.2M | May 15, 2026 |
| JPMORGAN CHASE & CO | Reduced | 29.5M | May 13, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 29.5M | May 15, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.